Max Delbrück Center for Molecular Medicine

The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) in Berlin, Germany is one of the sixteen research centers of the Helmholtz Association of German Research Centres.

Website
https://www.mdc-berlin.de/
Wikipedia
https://en.wikipedia.org/wiki/Max_Delbr%C3%BCck_Center_for_Molecular_Medicine_in_the_Helmholtz_Association

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Genetics

Gene editing precisely repairs immune cells

Some hereditary genetic defects cause an exaggerated immune response that can be fatal. Using the CRISPR-Cas9 gene-editing tool, such defects can be corrected, thus normalizing the immune response, as researchers led by Klaus ...

Oncology & Cancer

Hodgkin's lymphoma: Small changes in cells, big effect

Hodgkin's lymphoma is one of the most common types of lymphoma in young adults. It is characterized by the presence of enlarged B lymphocytes, which are unusual in that they bear on their surface the identifying markers of ...

Genetics

Mutation puts women at higher risk of heart failure

When the PRDM16 gene mutates, heart muscle cells undergo changes in their metabolism. This increases the risk of congenital heart failure in women more than men, as a ECRC research team led by Sabine Klaassen and Jirko Kühnisch ...

Oncology & Cancer

Zebrafish avatars can help tailor glioblastoma therapies

Scientists have created a new zebrafish xenograft platform to screen for novel treatments for an aggressive brain tumor called glioblastoma, according to a new study published in EMBO Molecular Medicine.

Genetics

Scientists genetically decode rare kidney disease

When Dr. Bodo Beck first saw the three children of a family who had fled Syria sitting in his consultation room at University Hospital Cologne, the human geneticist was surprised. His genetic analysis diagnosed Bartter syndrome ...

Genetics

Potential new biomarker for Alzheimer's discovered

Alzheimer's is considered a disease of old age, with most people being diagnosed after 65. But the condition actually begins developing, out of sight, many years before any symptoms emerge. Tiny proteins, known as amyloid-beta ...

page 1 from 9